Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation.

Autor: Theodore Hu1, Young Min Chung1, Guan, Michelle1, Ma, Michael1, Ma, Jessica1, Berek, Jonathan S.1, Hu, Mickey C.-T.1 mhu1@stanford.edu
Zdroj: Scientific Reports. 7/25/2014, p1-13. 13p.
Databáze: Academic Search Ultimate